AmorChem backs human cancers project
Canadian life sciences venture capital firm AmorChem has invested in a c-Myc-driven cancers project with Univalor, Montreal Clinical Research Institute and McGill University.
Canadian life sciences venture capital firm AmorChem has invested in a c-Myc-driven cancers project with Univalor, Montreal Clinical Research Institute and McGill University.
Copyright PEI Media
Not for publication, email or dissemination